{"id":602897,"date":"2026-09-01T19:32:20","date_gmt":"2026-09-01T19:32:20","guid":{"rendered":"https:\/\/www.newsbeep.com\/il\/602897\/"},"modified":"2026-09-01T19:32:20","modified_gmt":"2026-09-01T19:32:20","slug":"mizzou-researcher-leading-the-way-in-search-of-first-ever-treatment-for-common-heart-valve-disease","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/il\/602897\/","title":{"rendered":"Mizzou researcher leading the way in search of first-ever treatment for common heart valve disease"},"content":{"rendered":"<p>                <a href=\"https:\/\/www.eurekalert.org\/multimedia\/1149622\" rel=\"nofollow noopener\" target=\"_blank\"><\/p>\n<p>                    <img decoding=\"async\" src=\"https:\/\/www.newsbeep.com\/il\/wp-content\/uploads\/2026\/09\/1788291140_333_Public.jpeg\" alt=\"Dunpeng Cai\"\/><\/p>\n<p>                <\/a><\/p>\n<p>image:\u00a0<\/p>\n<p>Dunpeng Cai<\/p>\n<p>                  <a href=\"https:\/\/www.eurekalert.org\/multimedia\/1149622\" rel=\"nofollow noopener\" target=\"_blank\">view more\u00a0<\/a><\/p>\n<p class=\"credit\">Credit: University of Missouri<\/p>\n<p>University of Missouri researchers are advancing a promising new approach to treating a serious heart condition that affects millions of older adults worldwide.<\/p>\n<p>Dunpeng Cai, an assistant professor in the\u00a0<a href=\"https:\/\/medicine.missouri.edu\/\" rel=\"nofollow noopener\" target=\"_blank\">School of Medicine<\/a>, has received a five-year, $2.8 million National Institutes of Health R01 grant \u2014 one of the agency&#8217;s most competitive and prestigious awards \u2014 to uncover what causes aortic valve calcification. The progressive disease causes the heart&#8217;s aortic valve to harden and narrow over time, forcing the heart to work harder and leading to chest pain, shortness of breath and heart failure.<\/p>\n<p>Now, Cai is investigating what could become the first drug treatment for the disease.<\/p>\n<p>\u201cThe mechanisms driving aortic valve calcification are extremely complex, making the disease difficult to study,\u201d Cai said. \u201cMillions of patients are waiting for a treatment, and that makes this challenge worth pursuing.\u201d<\/p>\n<p>Working with clinicians at University Hospital, Cai previously compared healthy tissue and calcified human aortic valve tissue. At the time, he discovered that patients with aortic valve calcification have higher levels of DOCK2, a protein involved in regulating immune cells, within the cells of the aortic valve.<\/p>\n<p>The new grant will allow his team to test whether blocking DOCK2 with a drug can slow or prevent the disease.<\/p>\n<p>\u201cIf we can show that knocking out DOCK2 with a drug compound in animal models can slow, stop or even reverse the buildup of calcium in the aortic valve, the drug may also work in humans with the disease,\u201d Cai said. \u201cWhat\u2019s important to remember is that most proteins can have both a good side and a bad side. Since DOCK2 plays a key role in the immune system, the goal is to target its role in aortic valve calcification without causing unwanted side effects.\u201d<\/p>\n<p>As part of the grant, Cai\u2019s team will study aortic valve cells in the lab to better understand the role DOCK2 may play in driving the disease.<\/p>\n<p>If the approach proves successful, Cai plans to collaborate with researchers at the\u00a0<a href=\"https:\/\/precisionhealth.missouri.edu\/\" rel=\"nofollow noopener\" target=\"_blank\">Roy Blunt NextGen Precision Health<\/a>\u00a0building to advance a promising drug compound into clinical trials. NextGen Precision Health, along with the Genomics Technology Core in the\u00a0<a href=\"https:\/\/bondlsc.missouri.edu\/\" rel=\"nofollow noopener\" target=\"_blank\">Bond Life Sciences Center<\/a>, helps accelerate these types of discoveries, he said.<\/p>\n<p>\u201cAt some universities, researchers have to seek out these resources externally,\u201d Cai said. \u201cHaving world-class research infrastructure right on campus here at Mizzou helps us conduct our research much more efficiently.\u201d<\/p>\n<p>Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.<\/p>\n","protected":false},"excerpt":{"rendered":"image:\u00a0 Dunpeng Cai view more\u00a0 Credit: University of Missouri University of Missouri researchers are advancing a promising new&hellip;\n","protected":false},"author":2,"featured_media":602898,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[163,85,46],"class_list":["post-602897","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-health","tag-il","tag-israel"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/602897","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/comments?post=602897"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/602897\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media\/602898"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media?parent=602897"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/categories?post=602897"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/tags?post=602897"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}